TWD 28.95
(-9.95%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -262.58 Million TWD | -33.03% |
2022 | -197.38 Million TWD | 53.83% |
2021 | -427.51 Million TWD | -37.73% |
2020 | -310.39 Million TWD | 10.38% |
2019 | -346.35 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -213.26 Million TWD | 5.95% |
2024 Q1 | -226.75 Million TWD | 13.64% |
2023 Q4 | -262.58 Million TWD | -82.74% |
2023 FY | -262.58 Million TWD | -33.03% |
2023 Q3 | -143.69 Million TWD | 8.21% |
2023 Q2 | -156.54 Million TWD | 6.8% |
2023 Q1 | -167.97 Million TWD | 19.69% |
2022 FY | -197.38 Million TWD | 53.83% |
2022 Q4 | -209.14 Million TWD | 0.0% |
2021 FY | -427.51 Million TWD | -37.73% |
2020 FY | -310.39 Million TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -240.821% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 0.601% |
Level Biotechnology Inc. | -453.9 Million TWD | 42.15% |
Sagittarius Life Science Corp | -120.57 Million TWD | -117.784% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | -33.7% |
TaiMed Biologics Inc. | 499.84 Million TWD | 152.532% |
GlycoNex Incorporation | -148.56 Million TWD | -76.743% |
VBI | -25.31 Million TWD | -937.218% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 752.118% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 290.284% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 958.728% |
Visgeneer Inc. | 31.28 Million TWD | 939.349% |
Mycenax Biotech Inc. | 207 Million TWD | 226.846% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 61.419% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -95.589% |
Neith Corporation | -150.31 Million TWD | -74.692% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 142.247% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -355.413% |
Enimmune corporation | -314.15 Million TWD | 16.417% |
TaiRx, Inc. | -147.86 Million TWD | -77.577% |
CHO Pharma, Inc. | -203.79 Million TWD | -28.848% |
EirGenix Inc. | -4.58 Billion TWD | 94.277% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -209.784% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 317.242% |
Lin BioScience, Inc. | -3.21 Billion TWD | 91.841% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 17.276% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -1225.302% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 925.496% |
Lukas Biomedical Inc. | 50.75 Million TWD | 617.352% |
RBC Bioscience Corporation | 422.18 Million TWD | 162.196% |
BiOptic Inc. | 12.59 Million TWD | 2185.308% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 72.196% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -158.737% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -58.971% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 183.393% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -308.237% |
NaviFUS Corp. | -123.12 Million TWD | -113.258% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 454.596% |
Sinew Pharma Inc. | -160.34 Million TWD | -63.761% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -8.553% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 22.169% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 36.365% |
AP Biosciences Inc | -196.52 Million TWD | -33.61% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 138.125% |
3D Global Biotech Inc. | -11.43 Million TWD | -2195.899% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 68.352% |
Intech Biopharm Corporation | 1.35 Billion TWD | 119.346% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 36.709% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -25.434% |
TWi Biotechnology, Inc. | -143.86 Million TWD | -82.522% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 20.56% |
TCI GENE Inc. | -689.25 Million TWD | 61.903% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -120.772% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 79.943% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 1381.951% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -157.762% |
PharmaEngine, Inc. | -860.8 Million TWD | 69.496% |
Savior Lifetec Corporation | -812.54 Million TWD | 67.684% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 12.463% |
OBI Pharma, Inc. | -398.22 Million TWD | 34.062% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 28.142% |
Acepodia, Inc. | -6.02 Billion TWD | 95.638% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 92.281% |